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FOR THE MEASUREMENT of cytolytic
capacities expressed by effector cells in-
volved in cellular immunity, a variety of
cytotoxicity assays have been developed.
Although the widely used isotope-release
assays are generally more objective and
reliable than visual assays, such tests
involve numerous technical problems,
especially when consistent expression of
the cytocidal effector-cell capacity is
manifested only after prolonged inter-
action. In the present work, spontaneous
in vitro cytotoxicity expressed by macro-
phages and/or macrophage-like cells has
been assessed, using 3 isotope-release
assays: the 51Cr-release assay (CRA;
Cerottini et al., 1974) the [3H] proline-
release assay (PRA; Bean et al., 1973), and
the [14C] thymidine-release assay (TRA;
Keller, 1976b). In utilizing the same
effector and target cells, similar arrange-
ment and population density of cells
during the tests, it wasattempted toobtain
comparable experimental conditions.
The CRA was performed as described by
Cerottini et al. (1974). For the PRA, 0-3[Ci
L[3H]-proline/ml (20-40 Ci/mmol; New
England Nuclear, Boston, Mass.) was
added to target cells suspended at an
initial density of 2-5 x 105 cells/ml in
20 ml of RPMI-1640 medium, deficient in
proline but supplemented with 10°0
foetal calf serum (FCS). After 24h incu-
bation, cells were washed twice and
suspended in RPMI-1640 containing
23 mg/i proline and supplemented with
10°/ FCS. For the TRA, target cells
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seeded at an initial density of 2-5 x 105
cells/ml in 20 ml of RPMI-1640 supple-
mented with 10-6M uridine and 10% FCS
were labelled with 0-01 ttCi/ml [14C] thy-
midine (methyl-14C; 40-60 mCi/mmol;
New England Nuclear, Boston, Mass.).
After 20-24 h, the cells were washed twice
and resuspended in RPMI-1640 supple-
mented with 10-6M cold thymidine (TdR)
and 10% FCS. Adherent DA rat peritoneal
effector cells, obtained 3 days after i.p.
injection of proteose peptone (2 x 106
cells per 35 x 10mm dish) were interacted
for varying intervals with prelabelled
target cells (2 x 105/dish) in RMPI-1-640
medium supplemented with 100% FCS.
Two different controls were included: (a)
medium control containing only labelled
targets; (b) autologous control containing
unlabelled targets in place of, and at the
same concentration as effector cells
(Oldham et al., 1977). Tests were per-
formed in triplicate and percentage isotope
release was determined as previously
described (Keller, 1976b, 1978). It is note-
worthy that viability (assessed by trypan-
blue exclusion and residual cloning effici-
ency; Keller, 1974) and replication rate
(assessed by cell counts and pulse-labelling
with [3H]-TdR; Keller, 1974) ofthevarious
target-cell types (Tables I and II) was
neither affected by isotope labelling nor by
the presence of cold TdR (10-6M) and/or
proline (23 mg/l) in the post-labelling
phase. Moreover, autologous controls gave
isotope release similar to or lower than
mediium control.THREE ISOTOPE-RELEASE ASSAYS
TABLE 1.-Comparison of 10 Cell Types as Targets in the CRA
4h 8h 18h
Target-cell type
and origin
Mouse
MEPI
P-815
PU5-1 -8
IC-21-B4
DA Rat
ERF
REPI
DMBA-12
Py-12
rK A _A
I , ~ A
I
% % spontan. % % spontan. % % spontan.
cytotoxicity release cytotoxicity release cytotoxicity release
2 ( ± 3)
O ( ± 1)
4 ( ± 4)
O( ± 1)
2 ( ± 4)
2 ( ± 4)
0 ( ± 2)
4 ( ± 3)
10 ( ± 5)
8 ( ± 6)
22 ( ± 8)
21 ( ± 6)
24 ( ± 9)
18 ( ± 7)
9 ( ± 5)
38 ( ± 12)
1 ( ± 2)
6 ( ± 4)
3 (± 3)
1 (± 3)
2 ( ± 6)
2 ( ± 6)
3 ( ± 4)
1 (± 3)
18 ( ± 8)
17 ( ± 7)
29 ( ± 10)
31 ( ± 14)
28 ( 10)
27 ( ± 9)
12 ( ± 7)
46 ( ± 18)
6 ( ± 8)
20 ( ± 8)
4 ( ± 6)
1 (± 3)
7 (± 7)
4 ( ± 6)
25 ( ± 7)
2 ( ± 5)
23 ( ± 10)
21 ( ± 9)
45 ( ± 19)
44 ( ± 16)
35 ( ± 12)
37 ( ± 10)
18 ( ± 8)
56 ( ± 18)
Man
RAJI 1( 2) 9 ( 6) 1 ( 4) 15 ( 8) 9 ( 8) 22 ( 8)
RPMI 1( 3) 18 ( 9) 6 ( 5) 24 ( 9) 19 ( 9) 39 ( 17)
Initial effector/target-cell ratio was 10:1. Each value represents the mean of at least 20 determinations.
% cytotoxicity represents net isotope release.
Origin oftarget cells.-Early passages ofepidermis cells from the skin ofnormalBALB/c mice (MEPI) and
DA rats (REPI) were obtained as described by Hentzer and Kobayasi (1975). Early passages of DA rat
embryonic fibroblasts (ERF; Keller, 1976a) DA rat DMBA-induced fibrosarcoma cells growing as ascites
tumour (DMBA-12; Keller, 1977) DA rat polyoma-induced tumour cells (Py-12; Keller, 1973) DBA/2 murine mastocytoma P-815 cells (Keller, 1976a) SV40-transformed C57BL mouse macrophages (IC-21-B4; Keller, 1978) RPMI 7932 human melanoma cells (RPMI; Keller, 1976a) and the Burkitt's lymphoma cell
line RAJI (Keller, 1976a) were obtained as previously described. The BALB/c-derived monocyte cell line,
PU5-1 -8 (Ralph et al., 1977) was a gift from Dr P. Ralph.
TABLE II.-Comparison of 10 Cell Types as Targets in the PRA
(See footnote to Table I)
Target-cell type
and origin
Mouse
MEPI
P-815
PU5-1 - 8
IC-21-B4
DA Rat
ERF
REPI
DMBA-12
Py-12
Man
RAJI
RPMI
4h 8h 18h
I A
I --
% % spontan. % % spontan. % spontan.
cytotoxicity release cytotoxicity release cytotoxicity release
1 ( 1 2)
1 ( ± 2)
0 ( ± 1)
1 ( ± 2)
2 (± 3)
1 (±3)
2 ( ± 4)
1 ( ± 3)
13 ( ± 5)
11 ( ± 4)
29 ( ± 11)
17 ( ± 5)
17 ( ± 6)
18 ( ± 8)
11 ( ± 6)
18 ( ± 7)
3 ( ± 4)
5 ( ± 4)
2 ( ± 4)
4 ( ± 4)
5 ( ± 4)
3 ( ± 4)
8 ( ± 7)
2 ( ± 4)
17 ( ± 8)
16 ( ± 6)
33 ( ± 9)
23 ( ± 8)
21 ( ± 10)
22( ± 8)
16 ( ± 7)
26 ( ± 11)
19 ( ± 9)
38 ( ± 14)
7 ( ± 7)
11 ( ± 5)
14 ( ± 7)
14 ( ± 9)
33 ( ± 9)
15 ( ± 6)
24 ( ± 10)
19( ± 8)
51 ( ± 16)
31 ( ± 12)
26 ( ± 11)
29 ( ± 12)
20 ( ± 9)
28 ( ± 13)
0 ( ± 3) 19 ( ± 9) 6 ( ± 5) 23 ( ± 9) 13 ( ± 10) 32 ( ± 12) 0 ( ± 3) 15( ± 8) 2 ( ± 5) 21 ( ± 9) 15 ( ± 8) 27 ( ± 14)
In the CRA, the percent spontaneous
release of label differed considerably from
one target to another, but was uniformly
high after 18h culture (Table I). With the
longer-term PRA, isotope release effected
by macrophages was insignificant after 4
and/or 8h interaction but was consistently
detected after 18 (Table II) 30 or 48h.
-Spontaneous isotope release from pre-
labelled targets, although distinctly lower
70
than in the CRA, increased steadily as
incubation progressed, and reached a high
percentage already within 18h with the
more labile targets (Table II). With other
targets, it remained within acceptable
limits even after 30 and 48h. Results
obtained with the long-term TRA (Table
III) reflect a similar basic tendency to
those with the CRA and PRA. After 4and/
or 8h interaction, no or insignificant cyto-
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TABLE III.-Comparison of 10 Cell Types as Targets in TRA
(See footnote to Table I)
Target-cell type
and origin
Mouse
MEPI
P-815
PU5-1i8
IC-21-B4
DA Rat
ERF
REPI
DMBA-12
Py-12
Man
RAJI
RPMI
4h
% % spontan.
cytotoxicity release
6 ( ± 7)
4( ± 6)
3 ( ± 3)
7 ( ± 8)
6 ( ± 10)
6 ( ± 8)
6 ( ± 8)
10 ( ± 8)
8h 18h
% % spontan. % % spontan.
cytotoxicity release cytotoxicity release
7 ( 6) 11 ( 8)
9 ( 7) 10 ( 7)
16( ± 10) 6( -4- 6)
11 ( ± 6) 18 ( ± 12)
8 ( ± 7)
9 ( ± 7)
8 ( ± 4)
14 ( ± 11)
11 ( ± 9)
14 ( ± 8)
9 ( ± 10)
20 ( ± 8)
9 ( ± 7)
11 ( ± 8)
22 ( ± 14)
17 ( ± 10)
11 ( ± 10)
9 ( ± 6)
14 ( ± 12)
15 ( + 9)
24 ( ±
53 ( ±
14( ±
23 ( ±
26( +
29 ( ±
39 ( 1
29 ( ±
12)
16)
12)
14)
17)
13)
16)
10)
13 ( 8)
14( ± 9)
29 ( ± 20)
18 ( ± 11)
14( ± 9)
10 ( ± 10)
16 ( ± 12)
15 ( ± 8)
6 ( ± 5) 8 ( ± 6) 10 ( 1 8) 17 ( ± 10) 21 ( ± 15) 23 ( ± 12)
5(±+ 6) 9( ± 6) 10( ± 7) 10( ± 8) 29( I 16) 14( -- 11)
toxicity was detectable; significant net
isotope release was, however, consistently
observed after 18h and longer intervals. As
in the other assay systems, the various
target-cell types exhibited considerable
differences in their susceptibility to
effector-cell-mediated lysis, P-815 mouse
mastocytoma and DMBA-12 rat fibro-
sarcoma cells being among the most
sensitive targets (Table III). In the TRA,
spontaneous isotope release was generally
lower than in the CRA and PRA; thus,
both reproducibility and sensitivity were
highest in the TRA. After 18, 30 and 48h
interaction, the 2 longer-term assays gave
reproducible, largely corresponding results
(not shown). Spontaneous release in-
creased as interaction proceeded, thus
decreasing the sensitivity ofthe assays. In
parallel to these isotope-release assays, the
consequences of the interaction were
followed by counting residualP-815 masto-
cytoma cells. Results were similar to those
with polyoma-virus-induced DA rat
tumour cells (Keller et al., 1976), and
largely equalled those of longer-term
isotope-release assays.
In using 3 basically different isotope
release assays, in which the same effector
cells were interacted for identical intervals
and under comparable experimental con-
ditions with the same targets, the present
study clearly demonstrates that each
assay system and each target-cell type has
its special qualities and unique charac-
teristics, and is thus in keeping with other
recent work (Fossati et al., 1975; Oldham
et al., 1975; 1977; Ting et al., 1977).
Results of the present comparative
measurements show that a period of 18h
is required for the consistent expression of
spontaneous cytotoxicity by stimulated
macrophages, and thus confirm and extend
earlier observations based on morpho-
logical, cytological orisotope-releaseassays
(Keller, 1973, 1976a). It remains to be
determined whetherthisdelayis aproperty
inherent to the cytocidal process, or due
to poor experimental conditions such as
insufficient or inappropriate macrophage
activation (Russell etal., 1977). Thedelayed
expression of in vitro cytotoxicity by
adherent, predominantly phagocytic
macrophage-like cells is in sharp contrast
to the immediate cytotoxicity by cyto-
toxic T cells, K cells or 'natural killer'
cells. This implies that short-term cyto-
toxicity tests such as the CRA may not
suitably mirror the cytocidal process
mediated by macrophages.
The results of the present comparative
study, which included 10 different cell
types as targets and 3 isotope-release
assays to assess macrophage-mediated in
vitro cytotoxicity, once again point to the
important role of the target-cell type
involved. With some targets, such as
P-815, rat fibrosarcoma, MEPI and ERF,
the results were highly reproducible be-
cause of low spontaneous isotope-release.
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With other targets, particularly PU5-1-8
cells, spontaneous release was high in each
of the assay systems. As labelling of these
cells in no detectable manner affected their
viability or proliferation rate, this lability
may either be due to suboptimal culture
conditions orrepresent a property inherent
to these cell types.
In vitro assays for cell-mediated im-
munity are currently used extensively to
investigate immunological reactions
against cancer in man and in experimental
animal models. There is evidence that
various modifications ofmicrocytotoxicity
tests can be used to demonstrate reli-
ably lymphocyte-mediated cytotoxicity
(Takasugi and Klein, 1970; Hellstrbm and
Hellstrom, 1971; Jagarlamoody et al.,
1971; Cohen, 1973; Bean et al., 1974;
Oldham et al., 1977). Thus far, attempts in
this laboratory to adapt macrophage-
mediated cytolysis to the microcyto-
toxicity plate test have failed. Apart from
the requirement for prolonged interaction
and increased nutrient supply, the density
of macrophages in monolayers seems to be
a critical variable which might affect
their in vitro killer capacity (Russell et al.,
1977; Keller, unpublished).
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